Literature DB >> 15220216

Cosegregation of MIDD and MODY in a pedigree: functional and clinical consequences.

Camilla Cervin1, Brita Liljeström, Tiinamaija Tuomi, Seija Heikkinen, Juha S Tapanainen, Leif Groop, Corrado M Cilio.   

Abstract

The aim of this study was characterization of a family carrying two mutations known to cause monogenic forms of diabetes, the M626K mutation in the HNF1alpha gene (MODY3) and the A3243G in mtDNA. Beta-cell function and insulin sensitivity were assessed with the Botnia clamp. Heteroplasmy of the A3243G mutation and variants in type 2 diabetes susceptibility genes were determined, and transcriptional activity, DNA binding, and subcellular localization of mutated HNF1alpha were studied. Thirteen family members carried the mutation in mtDNA; 6 of them also had the M626K mutation, whereas none had only the M626K mutation. The protective Ala12 allele in peroxisome proliferator-activated receptor (PPAR)gamma was present in two nondiabetic individuals. Carriers of both mtDNA and HNF1alpha mutations showed an earlier age at onset of diabetes than carriers of only the mtDNA mutation (median 22 vs. 45 years) but no clear difference in beta-cell function or insulin sensitivity. In vitro, the M626K mutation caused a 53% decrease in transcriptional activity in HeLa cells. The mutated protein showed normal nuclear targeting but increased DNA binding. These data demonstrate that several genetic factors might contribute to diabetes risk, even in families with mtDNA and HNF1alpha mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220216     DOI: 10.2337/diabetes.53.7.1894

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

1.  Mitochondrial Diabetes is Associated with tRNALeu(UUR) A3243G and ND6 T14502C Mutations.

Authors:  Yu Ding; Shunrong Zhang; Qinxian Guo; Hui Zheng
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-03       Impact factor: 3.249

2.  Double heterozygous mutations involving both HNF1A/MODY3 and HNF4A/MODY1 genes: a case report.

Authors:  Gabriele Forlani; Stefano Zucchini; Antonio Di Rocco; Raffaella Di Luzio; Mirella Scipione; Elena Marasco; Giovanni Romeo; Giulio Marchesini; Vilma Mantovani
Journal:  Diabetes Care       Date:  2010-08-12       Impact factor: 19.112

3.  Phenotype variability and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene.

Authors:  Maciej Borowiec; Malgorzata Mysliwiec; Wojciech Fendler; Karolina Antosik; Agnieszka Brandt; Maciej Malecki; Wojciech Mlynarski
Journal:  Acta Diabetol       Date:  2011-03-25       Impact factor: 4.280

4.  Phenotypic and Genetic Heterogeneity in a Thai Glucokinase MODY Family Reveals the Complexity of Young-Onset Diabetes.

Authors:  Yotsapon Thewjitcharoen; Ekgaluck Wanothayaroj; Sirinate Krittiyawong; Soontaree Nakasatien; Tsz Fung Tsoi; Cadmon K P Lim; Juliana C N Chan; Thep Himathongkam
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

5.  Mitochondrial DNA sequence characteristics modulate the size of the genetic bottleneck.

Authors:  Ian J Wilson; Phillipa J Carling; Charlotte L Alston; Vasileios I Floros; Angela Pyle; Gavin Hudson; Suzanne C E H Sallevelt; Costanza Lamperti; Valerio Carelli; Laurence A Bindoff; David C Samuels; Passorn Wonnapinij; Massimo Zeviani; Robert W Taylor; Hubert J M Smeets; Rita Horvath; Patrick F Chinnery
Journal:  Hum Mol Genet       Date:  2016-01-05       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.